- Tytuł:
- ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
- Autorzy:
- Źródło:
- Cancer Immunology, Immunotherapy. 72(12):4145-4159
Czasopismo naukowe